Rejuvenation Technologies Inc.

Rejuvenation Technologies Inc. is a biotech company in Mountain View, United States, founded in 2016. It has raised $15.1M across 6 rounds, most recently a $325K Grant in September 2024.

We extend telomeres to extend the human health span

Employees
1–10
Founded
2016
Total Funding
$15.1M
Last Round
$325K GrantSep 2024
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 3 investors for this company. The full record is or through the API.

About

Rejuvenation Technologies develops therapies that rewind cellular mechanisms of aging, including therapeutic telomere extension. The company uses modified mRNA to temporarily activate telomerase, the enzyme that naturally extends telomeres, in specific cells. Short telomeres drive aging-related diseases including pulmonary fibrosis, liver disease, and bone marrow failure, and the company's technology aims to safely lengthen telomeres in those cells. Clinical trial plans include telomerase activation studies in pulmonary fibrosis, chronic liver disease, and hematologic conditions.

Summary

It lists 1–10 employees. It has raised $15.1M in total across 6 rounds, most recently a $325K Grant round in Sep 2024. Investors include Khosla Ventures, Shanda and Asymmetry Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase I (NIH)Sep 2024
$325K

Sign up to see all 6 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Rejuvenation Technologies Inc. on Indexed.vc
<a href="https://indexed.vc/companies/rejuvenation-tech"><img src="https://indexed.vc/api/badge/company/rejuvenation-tech" alt="Rejuvenation Technologies Inc. on Indexed.vc" width="260" height="76" /></a>